Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): October 6, 2003

                            STAAR SURGICAL COMPANY
            (Exact name of registrant as specified in its charter)

           Delaware                      0-11634                 95-3797439
(State or other jurisdiction      (Commission File Number)   (I.R.S. Employer
 of incorporation or organization)                           Identification No.)

 1911 Walker Avenue, Monrovia, California               91016
 (Address of principal executive offices)            (Zip Code)

                                 (626) 303-7902
              (Registrant's telephone number, including area code)

Item 7.  Financial Statements and Exhibits

      (c) Exhibits

Exhibit Number      Description
--------------      -----------

99.1                Press Release dated October 6, 2003.

Item 9.  Regulation FD Disclosure

      On October 6, 2003, STAAR Surgical Company (the "Company")  issued a press
release  announcing  that the U.S.  Food and  Drug  Administration  (the  "FDA")
Ophthalmic  Devices  Panel of the Center for  Devices and  Radiological  Health,
recommended that the Company's  Implantable Contact Lens (ICL), a phakic implant
used to correct  refractive  errors,  be  approved  with  conditions  for use in
correcting  myopia in the range of -3  diopters  to -15  diopters  and  reducing
myopia in the range of -15 diopters to -20 diopters. The FDA will consider these
recommendations  as it  completes  its  expedited  review of the ICL  Pre-Market
Approval application, which the Company submitted on May 8, 2003. However, there
can be no  assurance  that  the  FDA  will  follow  the  recommendations  of the
Ophthalmic Devices Panel.


      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

Date:    October 7, 2003                        STAAR SURGICAL COMPANY

                                                By: /s/ John Bily
                                                    John Bily
                                                    Chief Financial Officer


                                  Exhibit Index

--------------      -----------

99.1                Press Release dated October 6, 2003.